EDAP TMS Execs to Present at Oppenheimer Healthcare Conference
Event summary
- EDAP TMS SA to present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 18, 2026.
- CEO Ryan Rhodes and CFO Ken Mobeck will host virtual presentation and 1x1 investor meetings.
- Presentation scheduled for 12:00-12:30 PM ET.
- Webcast available via SummitCast link and EDAP TMS Investor Relations page.
The big picture
EDAP TMS's participation in the Oppenheimer conference underscores its push to solidify leadership in robotic energy-based therapies. The focus on Focal One® highlights the company's strategy to expand beyond prostate cancer, aligning with broader industry trends toward minimally invasive treatments. With a global footprint, EDAP TMS aims to leverage this platform to attract investors and partners in the competitive medtech space.
What we're watching
- Market Positioning
- How EDAP TMS will position Focal One® in expanding indications beyond prostate cancer.
- Investor Sentiment
- Whether the presentation will shift investor perception of EDAP TMS's growth trajectory.
- Technological Advancements
- The pace at which EDAP TMS integrates new technologies in imaging and robotics.
Related topics